Showing results (191-200 of 322) with videos related to
Sort By:
Pageof 33
The Journal of Experimental Medicine|July 1, 1985
Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in miceR L Kirkman, L V Barrett, G N Gaulton, et al.American Journal of Human Genetics|January 1, 1979
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complexD Raum, D Glass, C B Carpenter, et al.Nature Medicine|November 5, 1999
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft toleranceY Li, X C Li, X X Zheng, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gammaW Y Almawi, M L Lipman, A C Stevens, et al.Kidney International|May 1, 1980
Role of humoral presenitization in human renal transplant rejectionP Gailiunas, M Suthanthiran, G J Busch, et al.The Journal of Clinical Investigation|November 1, 1976
The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complementD Raum, D Glass, C B Carpenter, et al.Arthritis and Rheumatism|September 1, 1976
Association between HLA and cutaneous necrotizing venulitisD Glass, N A Soter, D Gibson, et al.Current Opinion in Immunology|October 1, 1996
The Th1/Th2 paradigm and the allograft responseT B Strom, P Roy-Chaudhury, R Manfro, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin AB S Wang, E H Heacock, Z Chang-Xue, et al.Transplantation|August 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipientsN L Tilney, W M Padberg, R H Lord, et al.Pageof 33